Eckert & Ziegler Strahlen- und Medizintechnik AG provided earnings guidance for the year 2022. For the current fiscal year 2022, the board expects an increase in sales to around EUR 200 million and a net income of around EUR 38 million. The forecast is based on a weighted average exchange rate of USD 1.20 per EUR and is subject to the assumption that no major disruptions continue to result from the developments in Ukraine.